<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2021-2669</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-2669</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МУЛЬТИФОКАЛЬНЫЙ АТЕРОСКЛЕРОЗ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MULTIFOCAL ATHEROSCLEROSIS</subject></subj-group></article-categories><title-group><article-title>Прогностическая значимость атеросклеротического поражения одного или двух сосудистых бассейнов у пациентов высокого и очень высокого сердечно-сосудистого риска</article-title><trans-title-group xml:lang="en"><trans-title>Prognostic significance of atherosclerosis of one or two vascular systems in patients with high and very high cardiovascular risk</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5902-3803</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Генкель</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Genkel</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, SPIN-код: 2519-6100.</p><p>Челябинск, Тел.: +7 (951) 441-70-61</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">henkel-07@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0357-5702</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, SPIN-код: 8397-0087.</p><p>Челябинск, Тел.: +7 (951) 441-70-61</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">alla.kusnezowa@googlemail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7954-2990</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебедев</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedev</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней, SPIN-код: 8194-3251.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">evgueni.lebedev@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7731-7730</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шапошник</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shaposhnik</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Доктор медицинских наук, профессор, зав. кафедрой пропедевтики внутренних болезней, SPIN-код: 3184-5994.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">shaposhnik@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Южно-Уральский государственный медицинский университет Министерства здравоохранения Российской Федерации</institution></aff><aff xml:lang="en"><institution>South Ural State Medical University</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>28</day><month>03</month><year>2021</year></pub-date><volume>20</volume><issue>2</issue><fpage>2669</fpage><lpage>2669</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Генкель В.В., Кузнецова А.С., Лебедев Е.В., Шапошник И.И., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Генкель В.В., Кузнецова А.С., Лебедев Е.В., Шапошник И.И.</copyright-holder><copyright-holder xml:lang="en">Genkel V.V., Kuznetsova A.S., Lebedev E.V., Shaposhnik I.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/2669">https://cardiovascular.elpub.ru/jour/article/view/2669</self-uri><abstract><sec><title>Цель</title><p>Цель. Изучить прогностическую значимость атеросклеротического поражения одного и нескольких сосудистых бассейнов у пациентов высокого и очень высокого сердечно-сосудистого риска (ССР).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В исследование включен 171 пациент высокого (26,9%) и очень высокого (73,1%) ССР. Всем пациентами проводили дуплексное ультразвуковое сканирование артерий каротидного бассейна и артерий нижних конечностей. Комбинированной конечной точкой (ККТ) являлась смерть от сердечно-сосудистых причин, нефатальный инфаркт миокарда, нефатальный инсульт, коронарная реваскуляризация.</p></sec><sec><title>Результаты</title><p>Результаты. Длительность периода наблюдения составила 31,1 (17,8; 47,9) мес. События, составляющие ККТ, произошли у 29 (16,9%) пациентов: сердечно-сосудистая смерть была зарегистрирована у 3 (1,75%) пациентов; нефатальный инфаркт миокарда — у 7 (4,09%) больных; нефатальный инсульт — у 6 (3,51%) больных; коронарная реваскуляризация — у 13 (7,60%) пациентов. Кумулятивная выживаемость пациентов высокого и очень высокого ССР, имеющих атеросклеротические бляшки в одном сосудистом бассейне, статистически значимо не отличалось от таковой у пациентов с интактными периферическими артериями (p=0,977). Бессобытийная выживаемость пациентов с сочетанным поражением сонных артерий и артерий нижних конечностей была статистически значимо ниже в сравнении с пациентами, имеющими поражение одного сосудистого бассейна (p=0,011). Сочетанное поражение сонных артерий и артерий нижних конечностей ассоциировалось с увеличением относительного риска (ОР) развития неблагоприятных сердечно-сосудистых событий — ОР 3,15 (95% доверительный интервал: 1,02-9,74; p=0,046) с поправкой на пол и возраст и наличие симптомов заболевания периферических артерий.</p></sec><sec><title>Заключение</title><p>Заключение. У пациентов высокого и очень высокого ССР атеросклеротическое поражение двух сосудистых бассейнов периферических артерий связано с увеличением ОР неблагоприятных сердечно-сосудистых событий с поправкой на пол, возраст и наличие симптомов поражения периферических артерий. Наличие атеросклеротических бляшек в одном сосудистом бассейне не ассоциировалось с увеличением риска событий, составляющих ККТ.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To study the prognostic significance of atherosclerosis of one and several vascular systems in patients with high and very high cardiovascular risk (CVR).</p></sec><sec><title>Material and methods</title><p>Material and methods. The study included 171 patients with high (26,9%) and very high (73,1%) CVR. All patients underwent duplex ultrasound of the carotid and lower limb arteries. The composite endpoint (CE) was cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, and coronary revascularization.</p></sec><sec><title>Results</title><p>Results. The follow-up period lasted 31,1 (17,8; 47,9) months. CE events occurred in 29 (16,9%) patients: cardiovascular death — 3 (1,75%) patients; nonfatal myocardial infarction — 7 (4,09%) patients; nonfatal stroke — 6 (3,51%) patients; coronary revascularization — 13 (7,60%) patients. Cumulative survival of patients with high and very high CVR with atherosclerotic plaques in the same vascular system did not significantly differ from that in patients with intact peripheral arteries (p=0,977). The event-free survival of patients with combined lesions of the carotid and lower limb arteries was significantly lower in comparison with patients with one vascular system involvement (p=0,011). The combined lesion of the carotid and lower limb arteries was associated with an increase in the relative risk (RR) of adverse cardiovascular events (RR, 3,15 (95% CI, 1,02-9,74; p=0,046), adjusted for sex, age, and peripheral arterial disease symptoms.</p></sec><sec><title>Conclusion</title><p>Conclusion. In patients with high and very high CVR, atherosclerotic lesion of two vascular systems of peripheral arteries is associated with an increase in the RR of adverse cardiovascular events, adjusted for sex, age, and peripheral arterial disease symptoms. The presence of atherosclerotic plaques in one vascular bed was not associated with an increase in the risk of CE events.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>атеросклероз</kwd><kwd>мультифокальный атеросклероз</kwd><kwd>сахарный диабет</kwd><kwd>неблагоприятные сердечно-сосудистые события</kwd></kwd-group><kwd-group xml:lang="en"><kwd>atherosclerosis</kwd><kwd>multifocal atherosclerosis</kwd><kwd>diabetes</kwd><kwd>adverse cardiovascular events</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lazzeroni D, Coruzzi P. Risk stratification in secondary cardiovascular prevention. Minerva Cardioangiol. 2018;66(4):471-6. doi:10.23736/S0026-4725.18.04648-0.</mixed-citation><mixed-citation xml:lang="en">Lazzeroni D, Coruzzi P. Risk stratification in secondary cardiovascular prevention. Minerva Cardioangiol. 2018;66(4):471-6. doi:10.23736/S0026-4725.18.04648-0.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Boitsov SA, Pogosova NV, Bubnova MG, et al. Cardiovascular prevention 2017. National guidelines. Russ J Cardiol. 2018;23(6):7-122. (In Russ.) Бойцов С.А., Погосова Н.В., Бубнова М.Г. и др. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018;23(6):7-122. doi:10.15829/1560-4071-2018-6-7-122.</mixed-citation><mixed-citation xml:lang="en">Boitsov SA, Pogosova NV, Bubnova MG, et al. Cardiovascular prevention 2017 National guidelines. Russ J Cardiol. 2018;23(6):7-122. (In Russ.) doi:10.15829/1560-4071-2018-6-7-122.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Annemans L, Packard CJ, Briggs A, Ray KK. 'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. Eur Heart J. 2018;39(27):2546-50. doi:10.1093/eurheartj/ehx710.</mixed-citation><mixed-citation xml:lang="en">Annemans L, Packard CJ, Briggs A, Ray KK. ‘Highest risk-hig-hest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies. Eur Heart J. 2018;39(27):2546-50. doi:10.1093/eurheartj/ehx710.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kontsevaya AV, Mukaneeva DK, Myrzamatova AO, et al. Economic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases in Russia in 2016. Cardiovascular Therapy and Prevention. 2020;19(1):48-55. (In Russ.) Концевая А.В., Муканеева Д.К., Мырзаматова А.О. и др. Экономический ущерб факторов риска, обусловленный их вкладом в заболеваемость и смертность от основных хронических неинфекционных заболеваний в российской федерации в 2016 году. Кардиоваскулярная терапия и профилактика. 2020;19(1):48-55. doi:10.15829/1728-8800-2020-1-2396.</mixed-citation><mixed-citation xml:lang="en">Kontsevaya AV, Mukaneeva DK, Myrzamatova AO, et al. Economic damage of risk factors associated with morbidity and mortality from major chronic non-communicable diseases in Russia in 2016. Cardiovascular Therapy and Prevention. 2020;19(1):48-55. (In Russ.) doi:10.15829/1728-8800-2020-1-2396.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations. VII revision. Atherosclerosis and dyslipidemia. 2020;1(38):7-40. (In Russ.) Кухарчук В.В., Ежов М.В., Сергиенко И.В. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. VII пересмотр. Атеросклероз и дислипидемии. 2020;1(38):7-40. doi:10.34687/2219-8202.JAD.2020.01.0002.</mixed-citation><mixed-citation xml:lang="en">Kukharchuk VV, Ezhov MV, Sergienko IV, et al. Diagnostics and correction of lipid metabolism disorders in order to prevent and treat atherosclerosis. Russian recommendations. VII revision. Atherosclerosis and dyslipidemia. 2020;1(38):7-40. (In Russ.) doi:10.34687/2219-8202.JAD.2020.01.0002.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Blankstein R, Chandrashekhar Y. Extensive Coronary Artery Calcifications: No Longer Primary Prevention! JACC Cardiovasc Imaging. 2020;13:183-185. doi:10.1016/j.jcmg.2019.12.007.</mixed-citation><mixed-citation xml:lang="en">Blankstein R, Chandrashekhar Y. Extensive Coronary Artery Calcifications: No Longer Primary Prevention! JACC Cardiovasc Imaging. 2020;13:183-185. doi:10.1016/j.jcmg.2019.12.007.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bonaca MP. Polyvascular disease and risk: When two is not better than one. Vasc Med. 2018;23(6):531-3. doi:10.1177/1358863X18796936.</mixed-citation><mixed-citation xml:lang="en">Bonaca MP. Polyvascular disease and risk: When two is not better than one. Vasc Med. 2018;23(6):531-3. doi:10.1177/1358863X18796936.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Gutierrez JA, Mulder H, Jones WS, et al. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. JAMA Netw Open. 2018;1(7):e185239. doi:10.1001/jamanetworkopen.2018.5239.</mixed-citation><mixed-citation xml:lang="en">Gutierrez JA, Mulder H, Jones WS, et al. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial. JAMA Netw Open. 2018;1(7):e185239. doi: 10.1001/jamanetworkopen.2018.5239.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q, Wang A, Zhang S, et al. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death. Atherosclerosis. 2017;262:1-7. doi:10.1016/j.atherosclerosis.2017.04.015.</mixed-citation><mixed-citation xml:lang="en">Zhang Q, Wang A, Zhang S, et al. Asymptomatic polyvascular disease and the risks of cardiovascular events and allcause death. Atherosclerosis. 2017;262:1-7 doi: 10.1016/j.atherosclerosis.201704.015.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Barbarash OL, Kashtalap VV. A patient with сoronary artery disease and multifocal atherosclerosis. how to optimize the prognosis? Medical advice. 2018;(16):32-8. (In Russ.) Пациент с ишемической болезнью сердца и мультифокальным атеросклерозом. Как оптимизировать прогноз? Медицинский совет. 2018;(16):32-8. doi:10.21518/2079-701X-2018-16-32-38.</mixed-citation><mixed-citation xml:lang="en">Barbarash OL, Kashtalap VV. A patient with aoronary artery disease and multifocal atherosclerosis. how to optimize the prognosis? Medical advice. 2018;(16):32-8. (In Russ.) doi: 10.21518/2079-701X-2018-16-32-38.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi:10.1093/eurheartj/ehx095.</mixed-citation><mixed-citation xml:lang="en">Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763-816. doi:10.1093/eurheartj/ehx095.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Mach F, Baigent C, Catapano AL, et al.; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation><mixed-citation xml:lang="en">Mach F, Baigent C, Catapano AL, et al.; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41 (1): 111-88. doi:10.1093/eurheartj/ehz455.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sprynger M, Rigo F, Moonen M, et al.; EACVI Scientific Documents Committee. Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. Eur Heart J Cardiovasc Imaging. 2018;19(11):1195-221. doi:10.1093/ehjci/jey103.</mixed-citation><mixed-citation xml:lang="en">Sprynger M, Rigo F, Moonen M, et al.; EACVI Scientific Documents Committee. Focus on echovascular imaging assessment of arterial disease: complement to the ESC guidelines (PARTIM 1) in collaboration with the Working Group on Aorta and Peripheral Vascular Diseases. Eur Heart J Cardiovasc Imaging. 2018;19(11):1195-221. doi:10.1093/ehjci/jey103.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rossello X, Bueno H, Pocock SJ, et al. Predictors of allcause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: results from the EPICOR registry. Clin Cardiol. 2019;42:111-9. doi:10.1002/clc.23116.</mixed-citation><mixed-citation xml:lang="en">Rossello X, Bueno H, Pocock SJ, et al. Predictors of allcause mortality and ischemic events within and beyond 1 year after an acute coronary syndrome: results from the EPICOR registry. Clin Cardiol. 2019;42:111-9. doi:10.1002/clc.23116.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Rossello X, Dorresteijn JA, Janssen A, et al. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol. 2019;26(14):1534-44. doi:10.1177/2047487319846715.</mixed-citation><mixed-citation xml:lang="en">Rossello X, Dorresteijn JA, Janssen A, et al. Risk prediction tools in cardiovascular disease prevention: A report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur J Prev Cardiol. 2019;26(14):1534-44. doi:10.1177/2047487319846715.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Calais F, Eriksson Östman M, Hedberg P, et al. Incremental prognostic value of coronary and systemic atherosclerosis after myocardial infarction. Int J Cardiol. 2018;261:6-11. doi:10.1016/j.ijcard.2018.02.035.</mixed-citation><mixed-citation xml:lang="en">Calais F, Eriksson Ostman M, Hedberg P, et al. Incremental prognostic value of coronary and systemic atherosclerosis after myocardial infarction. Int J Cardiol. 2018;261:6-11. doi:10.1016/j.ijcard.2018.02.035.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Eriksson Östman M, Calais F, Rosenblad A, et al. Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction. Atherosclerosis. 2017;263:53-9. doi:10.1016/j.atherosclerosis.2017.05.027.</mixed-citation><mixed-citation xml:lang="en">17 Eriksson Ostman M, Calais F, Rosenblad A, et al. Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction. Atherosclerosis. 2017;263:53-9. doi:10.1016/j.atherosclerosis.2017.05.027.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Miao B, Hernandez AV, Alberts MJ, et al. Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors. J Am Heart Assoc. 2020;9(2):e014402. doi:10.1161/JAHA.119.014402.</mixed-citation><mixed-citation xml:lang="en">Miao B, Hernandez AV, Alberts MJ, et al. Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors. J Am Heart Assoc. 2020;9(2):e014402. doi: 10.1161/JAHA.119.014402.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ershova AI, Boytsov SA, Drapkina OM, Balakhonova TV. Ultrasound markers of premanifest atherosclerosis of carotid and femoral arteries in assessment of cardiovascular risk. Russ J Cardiol. 2018;23(8):92-8. (In Russ.) Ершова А.И., Бойцов С.А., Драпкина О.М., Балахонова Т.В. Ультразвуковые маркеры доклинического атеросклероза сонных и бедренных артерий в оценке сердечно-сосудистого риска. Российский кардиологический журнал. 2018;23(8):92-8. doi:10.15829/1560-4071-2018-8-92-98.</mixed-citation><mixed-citation xml:lang="en">Ershova AI, Boytsov SA, Drapkina OM, Balakhonova TV. Ultrasound markers of premanifest atherosclerosis of carotid and femoral arteries in assessment of cardiovascular risk. Russ J Cardiol. 2018;23(8):92-8. (In Russ.) doi:10.15829/1560-4071-2018-8-92-98.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ershova AI, Balakhonova TV, Ivanova AA, et al. The problem of cardiovascular risk stratification depending on the severity of carotid and femoral artery atherosclerosis. Cardiovascular Therapy and Prevention. 2020;19(2):75-81. (In Russ.) Ершова А.И., Балахонова Т.В., Иванова А.А. и др. Проблема стратификации сердечно-сосудистого риска в зависимости от выраженности атеросклероза сонных и бедренных артерий. Кардиоваскулярная терапия и профилактика. 2020;19(2):75-81. doi:10.15829/1728-8800-2020-2441.</mixed-citation><mixed-citation xml:lang="en">Ershova AI, Balakhonova TV, Ivanova AA, et al. The problem of cardiovascular risk stratification depending on the severity of carotid and femoral artery atherosclerosis. Cardiovascular Therapy and Prevention. 2020;19(2):2441. (In Russ.) doi:10.15829/1728-8800-2020-2441.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Genkel VV, Kuznetsova AS, Sumerkina VS, et al. The prognostic value of various carotid ultrasound parameters in patients at high and very high cardiovascular risk. Int J Cardiol. 2019;292:225-9. doi:10.1016/j.ijcard.2019.06.038.</mixed-citation><mixed-citation xml:lang="en">Genkel VV, Kuznetsova AS, Sumerkina VS, et al. The prognostic value of various carotid ultrasound parameters in patients at high and very high cardiovascular risk. Int J Cardiol. 2019;292:225-9. doi:10.1016/j.ijcard.2019.06.038.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ihle-Hansen H, Vigen T, Ihle-Hansen H, et al. Prevalence of Carotid Plaque in a 63- to 65-Year-Old Norwegian Cohort From the General Population: The ACE (Akershus Cardiac Examination) 1950 Study. J Am Heart Assoc. 2018;7(10):e008562. doi:10.1161/JAHA.118.008562.</mixed-citation><mixed-citation xml:lang="en">Ihle-Hansen H, Vigen T, Ihle-Hansen H, et al. Prevalence of Carotid Plaque in a 63- to 65-Year-Old Norwegian Cohort From the General Population: The ACE (Akershus Cardiac Examination) 1950 Study. J Am Heart Assoc. 2018;7(10):e008562. doi:10.1161/JAHA.118.008562.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Genkel VV, Salashenko AO, Shamaeva TN, et al. Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus. Therapeutic archive. 2019;91(10):54-62. (In Russ.) Генкель В.В., Салашенко А.О., Шамаева Т.Н. и др. Атеросклероз периферических артерий у пациентов с ишемической болезнью сердца и сахарным диабетом 2-го типа. Терапевтический архив. 2019;91(10):54-62. doi:10.26442/00403660.2019.10.000106.</mixed-citation><mixed-citation xml:lang="en">Genkel VV, Salashenko AO, Shamaeva TN, et al. Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus. Therapeutic archive. 2019;91(10):54-62. (In Russ.) doi:10.26442/00403660.2019.10.000106.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y, Evans MA, Allison MA, et al. Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2019;282:202-9. doi:10.1016/j.atherosclerosis.2018.12.005.</mixed-citation><mixed-citation xml:lang="en">Zhao Y, Evans MA, Allison MA, et al. Multisite atherosclerosis in subjects with metabolic syndrome and diabetes and relation to cardiovascular events: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2019;282:202-9. doi:10.1016/j.atherosclerosis.2018.12.005.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Verma S, Mazer CD, Bhatt DL. The perils of polyvascular disease in type 2 diabetes. Lancet Diabetes Endocrinol. 2018;6(12):914-6. doi:10.1016/S2213-8587(18)30311-5.</mixed-citation><mixed-citation xml:lang="en">Verma S, Mazer CD, Bhatt DL. The perils of polyvascular disease in type 2 diabetes. Lancet Diabetes Endocrinol. 2018;6(12):914-6. doi:10.1016/S2213-8587(18)30311-5.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
